Our division has a highly productive track record across an array of basic, translational, and clinical research areas. Please see individual faculty profiles for details.
- Our research is funded by a variety of sponsors including but not limited to the NIH, foundations (e.g., Vascular Cures), and industry.
- We work in a multidisciplinary fashion with engineers, psychologists, computer scientists, implementation science experts, and many others to address the pressing issues facing our patients.
- We have a robust research infrastructure and experienced research coordinators for IRB submission, patient enrollment, data storage, and analysis.
- We engage a variety of learners in our work including medical students, general surgery residents, vascular surgery fellows, and postdoctoral fellows.
Selected Project Highlights
- R01, NHLBI, Sal Scali: Exploring mechanisms responsible for dialysis-access related hand dysfunction
- R01, NHLBI, Sal Scali: Determining the influence of the uremic milieu on skeletal muscle mitochondrial bioenergetics among patients with PAD
- K23, NHLBI, Samir K Shah: Outcomes and perspectives on treatment for critical limb ischemia in patients with end-stage renal disease.
- AGING Initiative, Samir K Shah. Patient goals and decision-making in chronic limb-threatening ischemia
- R01, NHLBI, Zhihua Jiang, Gilbert Upchurch: Role of RNA-mediated danger signals in regulating TAAD development
- R01, NHLBI, Zhihua Jiang, Gilbert Upchurch: Immune injury as a driver for the development of ascending aortic aneurysms and dissections
- Martin Back: Safety of celiac artery exclusion during TEVAR and complex EVAR
- Martin Back: Limits of thoracic aortic remodeling and late anatomic changes after TEVAR for type B aortic dissection
Selected Ongoing Industry-Sponsored Clinical Trials
- Gore TAMBE Pararenal/TAAA study
- LimFlow Promise III
- Nectero stAAAble
- Humacyte AVF
- Terumo Osprey Iliac